Phase I trial of a monoclonal antibody specific for α vβ3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion
Producción científica: Article › revisión exhaustiva
145Citas
(Scopus)
Huella
Profundice en los temas de investigación de 'Phase I trial of a monoclonal antibody specific for α vβ3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion'. En conjunto forman una huella única.
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science